1. Ferlay, J., et al. International Cancer Observatory: Cancer Right now. (Worldwide Company for Analysis on Cancer, Lyon, France, 2024).
2. Crosby, D., et al. Early detection of cancer. Science 375, eaay9040 (2022).
3. Sasieni, P., et al. Modelled mortality advantages of multi-cancer early detection screening in England. British Journal of Cancer 129, 72–80 (2023).
4. Henderson, J.T., Webber, E.M. & Sawaya, G.F. Screening for Ovarian Cancer: Up to date Proof Report and Systematic Evaluation for the US Preventive Providers Process Power. Jama 319, 595–606 (2018).
5. Henrikson, N.B., et al. Screening for Pancreatic Cancer: Up to date Proof Report and Systematic Evaluation for the US Preventive Providers Process Power. Jama 322, 445–454 (2019).
6. Janfaza, S., Khorsand, B., Nikkhah, M. & Zahiri, J. Digging deeper into risky natural compounds related to cancer. Biol Strategies Protoc 4, bpz014 (2019).
7. Monedeiro, F., Dos Reis, R.B., Peria, F.M., Sares, C.T.G. & De Martinis, B.S. Investigation of sweat VOC profiles in evaluation of cancer biomarkers using HS-GC-MS. J Breath Res 14, 026009 (2020).
8. Deng, C., Zhang, X. & Li, N. Investigation of risky biomarkers in lung cancer blood using solid-phase microextraction and capillary gasoline chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 808, 269–277 (2004).
9. Wang, C., et al. Blood risky compounds as biomarkers for colorectal cancer. Cancer Biol Ther 15, 200–206 (2014).
10. Xue, R., et al. Investigation of risky biomarkers in liver cancer blood using solid-phase microextraction and gasoline chromatography/mass spectrometry. Fast Commun Mass Spectrom 22, 1181–1186 (2008).
11. Monedeiro, F., Monedeiro-Milanowski, M., Zmysłowski, H., De Martinis, B.S. & Buszewski, B. Analysis of salivary VOC profile composition directed in direction of oral cancer and oral lesion evaluation. Clin Oral Investig 25, 4415–4430 (2021).
12. Silva, C.L., Passos, M. & Câmara, J.S. Investigation of urinary risky natural metabolites as potential cancer biomarkers by solid-phase microextraction together with gasoline chromatography-mass spectrometry. Br J Cancer 105, 1894–1904 (2011).
13. da Costa, B.R.B. & De Martinis, B.S. Evaluation of urinary VOCs using mass spectrometric strategies to diagnose cancer: A assessment. Clin Mass Spectrom 18, 27–37 (2020).
14. Feil, C., et al. Sniffer canine can establish lung cancer sufferers from breath and urine samples. BMC Cancer 21, 917 (2021).
15. Warli, S.M., Firsty, N.N., Velaro, A.J. & Tala, Z.Z. The Olfaction Potential of Medical Detection Canine to Detect Prostate Cancer From Urine Samples: Progress Captured in Systematic Evaluation and Meta-Evaluation. World J Oncol 14, 358–370 (2023).
16. Sonoda, H., et al. Colorectal cancer screening with odour materials by canine scent detection. Intestine 60, 814–819 (2011).
17. Ehmann, R., et al. Canine scent detection within the analysis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J 39, 669–676 (2012).
18. McCulloch, M., et al. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther 5, 30–39 (2006).
19. Lippi, G. & Cervellin, G. Canine olfactory detection of cancer versus laboratory testing: delusion or alternative? Clin Chem Lab Med 50, 435–439 (2012).
20. Horvath, G., Jarverud, G.A., Jarverud, S. & Horvath, I. Human ovarian carcinomas detected by particular odor. Integr Cancer Ther 7, 76–80 (2008).
21. McCulloch, M., Turner, Ok. & Broffman, M. Lung cancer detection by canine scent: will there be a lab within the lab? Eur Respir J 39, 511–512 (2012).
22. Bauër, P., et al. Distant Medical Scent Detection of Cancer and Infectious Ailments With Canine and Rats: A Systematic Evaluation. Integr Cancer Ther 21, 15347354221140516 (2022).
23. Moser, E. & McCulloch, M. Canine scent detection of human cancers: A assessment of strategies and accuracy. Journal of Veterinary Habits 5, 145–152 (2010).
24. Junqueira, H., et al. Accuracy of Canine Scent Detection of Non-Small Cell Lung Cancer in Blood Serum. J Am Osteopath Assoc (2019).
25. Pirrone, F. & Albertini, M. Olfactory detection of cancer by trained sniffer canine: A scientific assessment of the literature. Journal of Veterinary Habits 19, 105–117 (2017).
26. Hackner, Ok., et al. Canine scent detection for the analysis of lung cancer in a screening-like state of affairs. J Breath Res 10, 046003 (2016).
27. Duan, Y., Edwards, J.S. & Dwivedi, Y.Ok. Artificial intelligence for resolution making within the period of Massive Knowledge – evolution, challenges and analysis agenda. Worldwide Journal of Info Administration 48, 63–71 (2019).
28. Haleem, A., Javaid, M. & Khan, I.H. Present standing and purposes of Artificial Intelligence (AI) in medical discipline: An outline. Present Medication Analysis and Apply 9, 231–237 (2019).
29. AJCC Cancer Staging Guide, (Springer Cham, 2017).
30. Nationwide Cancer Plan. (Nationwide Cancer Institute On the Nationwide Institutes of Well being, Bethesda, MD, 2024).
31. Shao, S.H., et al. Multi-cancer early detection check sensitivity for cancers with and with out present population-level screening choices. Tumori 109, 335–341 (2023).
32. Amundsen, T., Sundstrøm, S., Buvik, T., Gederaas, O.A. & Haaverstad, R. Can canine odor lung cancer? First study using exhaled breath and urine screening in unselected sufferers with suspected lung cancer. Acta Oncologica 53, 307–315 (2014).
33. Jonas, D.E., et al. Screening for Lung Cancer With Low-Dose Computed Tomography: Up to date Proof Report and Systematic Evaluation for the US Preventive Providers Process Power. JAMA 325, 971–987 (2021).
34. Ohuchi, N., et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to display for breast cancer within the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised managed trial. The Lancet 387, 341–348 (2016).
35. Zeeshan, M., Salam, B., Khalid, Q.S.B., Alam, S. & Sayani, R. Diagnostic Accuracy of Digital Mammography within the Detection of Breast Cancer. Cureus 10, e2448 (2018).
36. Lee, J.Ok., Liles, E.G., Bent, S., Levin, T.R. & Corley, D.A. Accuracy of fecal immunochemical exams for colorectal cancer: systematic assessment and meta-analysis. Ann Intern Med 160, 171 (2014).
37. Imperiale, T.F., Gruber, R.N., Stump, T.E., Emmett, T.W. & Monahan, P.O. Efficiency Traits of Fecal Immunochemical Assessments for Colorectal Cancer and Superior Adenomatous Polyps: A Systematic Evaluation and Meta-analysis. Ann Intern Med 170, 319–329 (2019).
38. Merriel, S.W.D., et al. Systematic assessment and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic sufferers. BMC Medication 20, 54 (2022).
39. Farooq, M., et al. Blood-based multi-cancer detection: A state-of-the-art replace. Present Issues in Cancer 48, 101059 (2024).
40. Klein, E.A., et al. Scientific validation of a focused methylation-based multi-cancer early detection check using an unbiased validation set. Ann Oncol 32, 1167–1177 (2021).
41. Schrag, D., et al. Blood-based exams for multicancer early detection (PATHFINDER): a prospective cohort study. Lancet 402, 1251–1260 (2023).
42. Nicholson, B.D., et al. Multi-cancer early detection check in symptomatic sufferers referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study. Lancet Oncol 24, 733–743 (2023).
43. Biehl, W., et al. VOC sample recognition of lung cancer: a comparative analysis of various dog- and eNose-based methods using totally different sampling supplies. Acta Oncologica 58, 1216–1224 (2019).
44. Mandrekar, S.J., Dahlberg, S.E. & Simon, R. Enhancing Scientific Trial Effectivity: Pondering outdoors the Field. Am Soc Clin Oncol Educ Ebook, e141-147 (2015).